Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety
NCT00721526Phase 4Completed
- Sponsor
- The University of New Mexico
- Start
- Aug 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of disulfiram and lorazepam in alcohol dependence and anxiety disorder, sponsored by The University of New Mexico. Primary endpoints: Treatment Adherence (Retention) at 16 weeks and Percent Days Abstinent. Started Aug 2009; status: completed.
02
Drugs
disulfiramlorazepam
03
Conditions
alcohol dependenceanxiety disorder
Beyond the preview
Go deeper on NCT00721526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00721526.